Chair of Translational Oncology
Our main focus is on:
- Identification of molecular targets and development of targeted therapies for the treatment of tumors of the lymphohematopoietic system
- Development of immunotherapies with bispecific antibodies
- Early Clinical Development: planning and conduction of clinical phase -I, -I/II trials in the field of Oncology
- Head of the Comprehensive Cancer Center Mainfranken
- Head of the Early Clinical Trial Unit (ECTU) and
- Trial Office of the CCC Mainfranken
- Head of the Division Hemato-Oncology of the Department of Internal Medicine II
- Head of the Division of Hematology/Oncology of the Department of Internal Medicine II
